Breaking News Headlines Today

News from lifesciencesbc.ca

Stay current with all the latest and breaking news from lifesciencesbc.ca. Compare headlines and media bias behind news outlets on stories breaking today.

We’ve aggregated 50 of lifesciencesbc.ca’s headlines and news stories over the past 3 months.

Ground News rates lifesciencesbc.ca’s media bias as unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

lifesciencesbc.ca’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about lifesciencesbc.ca

Where is lifesciencesbc.ca located?lifesciencesbc.ca's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top lifesciencesbc.ca News

Vancouver, British Columbia · Vancouver

Zymeworks Strengthens Board of Directors with Appointments of Greg Ciongoli and Robert E. Landry - Zymeworks (NASDAQ:ZYME)

Coverage: 4 sources

VANCOUVER, British Columbia, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (NASDAQ:ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease, today announced the appointments of Greg Ciongoli and Robert E. Landry to the Company's Board of Directors, effective August…See the Story

Research · Vancouver

MS Could Start up to 15 Years Earlier than Thought, New UBC Research Suggests

100% Left coverage: 1 sources

Research from the University of British Columbia suggests signs of multiple sclerosis could appear up to 15 years before classical symptoms develop.See the Story

Vancouver, British Columbia · Vancouver

The ISSCR and STEMCELL Technologies Partner to Launch Free, On-Demand Course on Standards for Human Stem Cell Use in Research - Life Sciences British Columbia

Open the article to view the coverage from lifesciencesbc.ca Read Article

Genome BC Funds Research into the Respiratory Fallout of Wildfires - Life Sciences British Columbia

Genome BC is funding three research projects that will delve into the genetic-level impacts of wildfire smoke exposure.Wildfires · Vancouver See the Story

Cytiva Expands Collaboration with Culture Biosciences

Cytiva expanded its collaboration with Culture Biosciences, which specializes in cloud-connected bioreactor technology, to include both hardware commercialization and technology development. Building on an existing agreement to offer a Cytiva 250mL consumable featuring a scaled-down version of its Xcellerex X-Platform technology for use with Culture’s Stratyx 250 system, the expanded relationship will now include global commercialization by Cyti…Vancouver, British Columbia · Vancouver See the Story

BC Researchers Use Genomics to Tackle Drug Resistance, Brain Disorders and More - Life Sciences British Columbia

Genomics is powering new ways to fight infection, improve drug safety and deliver treatments straight to where they’re needed.DNA · Vancouver Read Article

Kapoose Creek Bio Welcomes Renowned Drug Discovery Leader Dr. Stewart Fisher to Board of Directors - Life Sciences British Columbia

VANCOUVER, BC – Kapoose Creek Bio is delighted to announce the appointment of Dr. Stewart Fisher to its Board of Directors. Globally recognized as a trailblazer in drug discovery and development, Dr. Fisher brings more than 25 years of transformative leadership across the pharmaceutical and biotech industries. A distinguished authority in enzymology and medicinal chemistry, Dr. Fisher most recently served as Chief Scientific Officer at C4 Therap…Vancouver, British Columbia · Vancouver Read Article

ARC Medical Announces IPCOAT™ Medical Device Presentations at AAGL 2025 - Life Sciences British Columbia

VANCOUVER, BC – ARC Medical Inc., a clinical stage medical device company focused on advancing surgical adhesion prevention, announced that three scientific abstracts highlighting one of its lead medical devices, IPCOAT™, have been accepted for presentation at the 2025 AAGL 54th Global Congress on Minimally Invasive Gynecologic Surgery, taking place November 8–11 in Vancouver, BC, Canada. The accepted abstracts include ARC Medical’s first-in-hum…Vancouver, British Columbia · Vancouver Read Article

CDA Issues Positive Reimbursement Recommendation for SKYCLARYS™ (omaveloxolone), the Only Health Canada-Approved Treatment for Managing Friedreich Ataxia - Life Sciences British Columbia

Biogen Canada announces the positive reimbursement recommendation by the Canada Drug Agency Canadian Drug Expert Committee for SKYCLARYS™.Health Canada · British Columbia Read Article

Acuitas Therapeutics’ Scientists Collaborate with the University of Zurich and the University of Pennsylvania to Develop a Novel Deep Learning Model for Efficient Adenine Base Editing - Life Sciences British Columbia

Acuitas Therapeutics announced publication “Predicting adenine base editing efficiencies in different cellular contexts by deep learning."Vancouver, British Columbia · Vancouver Read Article

Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease

100% Left coverage: 2 sources

DURECT's lead asset, Larsucosterol, is an epigenetic modulator with FDA Breakthrough Therapy DesignationPotential to be the first FDA-approved therapeutic option for the treatment of patients with alcoholic hepatitisProposed acquisition strengthens Bausch Health's commitment to hepatology and patients suffering with liver…Corsicana · Corsicana See the Story

News from lifesciencesbc.ca

News from lifesciencesbc.ca

Information about lifesciencesbc.ca

Media Bias Ratings

Factuality

Ownership

Top lifesciencesbc.ca News

Zymeworks Strengthens Board of Directors with Appointments of Greg Ciongoli and Robert E. Landry - Zymeworks (NASDAQ:ZYME)

MS Could Start up to 15 Years Earlier than Thought, New UBC Research Suggests

The ISSCR and STEMCELL Technologies Partner to Launch Free, On-Demand Course on Standards for Human Stem Cell Use in Research - Life Sciences British Columbia

Genome BC Funds Research into the Respiratory Fallout of Wildfires - Life Sciences British Columbia

Cytiva Expands Collaboration with Culture Biosciences

BC Researchers Use Genomics to Tackle Drug Resistance, Brain Disorders and More - Life Sciences British Columbia

Kapoose Creek Bio Welcomes Renowned Drug Discovery Leader Dr. Stewart Fisher to Board of Directors - Life Sciences British Columbia

ARC Medical Announces IPCOAT™ Medical Device Presentations at AAGL 2025 - Life Sciences British Columbia

CDA Issues Positive Reimbursement Recommendation for SKYCLARYS™ (omaveloxolone), the Only Health Canada-Approved Treatment for Managing Friedreich Ataxia - Life Sciences British Columbia

Acuitas Therapeutics’ Scientists Collaborate with the University of Zurich and the University of Pennsylvania to Develop a Novel Deep Learning Model for Efficient Adenine Base Editing - Life Sciences British Columbia

Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease

Similar News Topics

Topics Most Covered by lifesciencesbc.ca

Sources Covering Similar Topics

Breaking News Topics Related to lifesciencesbc.ca

Information about lifesciencesbc.ca

Media Bias Ratings

Factuality

Ownership

Genome BC Funds Research into the Respiratory Fallout of Wildfires - Life Sciences British Columbia

Cytiva Expands Collaboration with Culture Biosciences

BC Researchers Use Genomics to Tackle Drug Resistance, Brain Disorders and More - Life Sciences British Columbia

Kapoose Creek Bio Welcomes Renowned Drug Discovery Leader Dr. Stewart Fisher to Board of Directors - Life Sciences British Columbia

ARC Medical Announces IPCOAT™ Medical Device Presentations at AAGL 2025 - Life Sciences British Columbia

CDA Issues Positive Reimbursement Recommendation for SKYCLARYS™ (omaveloxolone), the Only Health Canada-Approved Treatment for Managing Friedreich Ataxia - Life Sciences British Columbia

Acuitas Therapeutics’ Scientists Collaborate with the University of Zurich and the University of Pennsylvania to Develop a Novel Deep Learning Model for Efficient Adenine Base Editing - Life Sciences British Columbia

Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease